Johnson Controls Launches Integrated Laboratory Services - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Johnson Controls Launches Integrated Laboratory Services



Johnson Controls announced an improved Integrated Laboratory Services (ILS) for the life-sciences market at Pittcon 2014, which includes a range of specialist solutions to help customers increase operational and financial efficiencies and manage risk within their R&D, manufacturing, data center, HQ, and warehousing facilities.

Johnson Controls is responsible for delivering IFM & lab services and supporting quality and compliance for 100 million ft2 of life-science facilities globally, with 40% of those facilities being regulated space.

The life-sciences team has developed a new scientific asset visualization tool, a reporting and analytics tool that enables data-driven decisions and delivers improved lab functions through dashboards and reports, interpreting various data sources, and utilizing its global data warehouse for Integrated Laboratory Services.

Source: Johnson Controls

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
28%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
9%
All of the above.
45%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing

Click here